Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Linagliptin may cause hair loss and skin blisters.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Upadacitinib effectively treats psoriasis and lichen planus together.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tirzepatide may improve hair loss by reducing insulin resistance.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

A woman with severe angioedema improved significantly after treatment with rituximab.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Rituximab can cause skin issues, but baricitinib may help improve them.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.